GenomeWeb

@GenomeWeb

Highlighting the best of GenomeWeb's coverage of the genomics sector. Maintained by Bernadette Toner, CEO.

New York, NY
ಏಪ್ರಿಲ್ 2011 ಸಮಯದಲ್ಲಿ ಸೇರಿದ್ದಾರೆ

ಟ್ವೀಟ್‌ಗಳು

ನೀವು @GenomeWeb ಅವರನ್ನು ತಡೆಹಿಡಿದಿರುವಿರಿ

ಈ ಟ್ವೀಟ್‌ಗಳನ್ನು ವೀಕ್ಷಿಸಲು ನೀವು ಖಚಿತವಾಗಿ ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ ವೀಕ್ಷಣೆಯು @GenomeWeb ಅವರ ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ

  1. ಡಿಸೆಂ 11

    New draft bill aims to establish a framework for FDA oversight of in vitro clinical tests

    ರದ್ದುಗೊಳಿಸು
  2. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 11
    ರದ್ದುಗೊಳಿಸು
  3. ಡಿಸೆಂ 7

    Join our webinar to review a study that used two independent platforms to gain insight into the impact of different types of aneuploidies during preimplantation

    ರದ್ದುಗೊಳಿಸು
  4. ಡಿಸೆಂ 5

    How can you use precision to identify patients at risk for invasive infection? Find out during our sponsored webinar on 12/12

    ರದ್ದುಗೊಳಿಸು
  5. ಡಿಸೆಂ 5

    The Australian researchers plan to use the technique in an exome sequencing study of 25,000 individuals with epilepsy and aim to develop it into a clinical test.

    ರದ್ದುಗೊಳಿಸು
  6. ನವೆಂ 30

    He Jiankui calls CCR5 germline editing an "unmet medical need," but scientists are using other terminology: "crazy," "stupendously unethical," "disturbing," "premature," and "way out of step with the morality of the community."

    ರದ್ದುಗೊಳಿಸು
  7. ನವೆಂ 21

    Researchers investigated the possibility of picking up intra-tumor genetic heterogeneity in tumor exomes, identifying false-positives and technical noise.

    ರದ್ದುಗೊಳಿಸು
  8. ನವೆಂ 20

    In a poster presented at AMIA, just one-third of IGNITE participants had external structured genomic test results in their EHRs to inform clinical decision support.

    ರದ್ದುಗೊಳಿಸು
  9. ನವೆಂ 19

    Join Stephen Mack of during our 11/27 webinar as he defines a framework for integrating -omics data to discover & confirm novel drug targets in high-risk neurological models

    ರದ್ದುಗೊಳಿಸು
  10. ನವೆಂ 16

    Researchers identified immune activity changes in first-trimester placenta and decidua samples profiled through single-cell RNA sequencing.

    ರದ್ದುಗೊಳಿಸು
  11. ನವೆಂ 16

    Illumina touted PacBio's accuracy, technology roadmap, and potential clinical applications as key to why the company wanted to acquire it.

    ರದ್ದುಗೊಳಿಸು
  12. ನವೆಂ 13

    Researchers reached clinical diagnoses in 35 percent of cases undergoing evaluation over 20 months, sometimes leading to treatment changes.

    ರದ್ದುಗೊಳಿಸು
  13. ನವೆಂ 8

    Join our webinar on 11/15 for a discussion on Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

    ರದ್ದುಗೊಳಿಸು
  14. ನವೆಂ 7

    NX Prenatal and Indiana University School of Medicine are collaborating to develop exosome blood tests for preterm birth risk and preeclampsia.

    ರದ್ದುಗೊಳಿಸು
  15. ಅಕ್ಟೋ 26

    BGI launches higher-throughput sequencer, claims 24 hour turnaround for human genome with $100 in reagent costs

    ರದ್ದುಗೊಳಿಸು
  16. ಅಕ್ಟೋ 25

    European effort developing -compliant guidelines for sharing health data

    ರದ್ದುಗೊಳಿಸು
  17. ಅಕ್ಟೋ 22

    Miss , or just couldn't get to all the talks? Check out our coverage on our ASHG page:

    ರದ್ದುಗೊಳಿಸು
  18. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಅಕ್ಟೋ 1

    The approved 's NGS test for minimal residual disease, and created a new classification making it possible for similar tests to go through the 510(k) clearance process

    ರದ್ದುಗೊಳಿಸು
  19. ಅಕ್ಟೋ 2

    What method for whole-exome of formalin-fixed paraffin embedded (FFPE) tissue do you use? Join our webinar on 10/9 for a comparison of different methods

    ರದ್ದುಗೊಳಿಸು
  20. ಸೆಪ್ಟೆಂ 24

    How do you maximizing efficiency in a modern microbiology lab without impacting quality? Learn how during our sponsored webinar

    ರದ್ದುಗೊಳಿಸು

ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.

Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.

    ಇದನ್ನೂ ಸಹ ನೀವು ಇಷ್ಟಪಡಬಹುದು

    ·